E · J · F
Eduardo J. Fernandez~~Eugene L. Chang~~Grégory de Saxcé~~Jonathan J. Konoff
January 23, 2026
Firm Represents PAI in Proposed Acquisition of ELITech from Ergon Capital
1 min
AI-made summary
- PAI Partners has entered into exclusive negotiations with Ergon Capital Partners and ELITech Group's management for the acquisition of ELITech Group, a manufacturer of specialty in-vitro diagnostics equipment and reagents
- The transaction is subject to customary works councils’ information and consultation procedures and antitrust clearance
- ELITech operates in molecular diagnostics, microbiology, and clinical chemistry
- The deal involves a cross-border legal team from Willkie, with offices in Paris, New York, and Milan.
national partners Gregory DeSaxcé, special European counsel Jeffrey Fouts and associates Marie Aubard and Camille Rezette (corporate); special European counsel Charles-Antoine Erignac and associate Perrine Saunier (regulatory); and partner David Tayar and associate Anouk Falgas (antitrust); New York -- partner Eugene Chang and associate Andrea de Vos (IP); counsel Jonathan Konoff (antitrust), associate Peter Melampy (corporate), law clerk Peter Coulson (litigation) and due diligence attorney Samuel Neill; and Milan
E
Article Author
Eduardo J. Fernandez~~Eugene L. Chang~~Grégory de Saxcé~~Jonathan J. Konoff
The Sponsor